Below are some training materials related to the effects of tobacco use in various populations. This includes presentations by Dr. Okoli and a testimonial of a teenage Juul user from North Carolina.

This presentation focuses on tobacco use in populations living with mental illness. It discusses the importance of recognizing tobacco treatment in the behavioral health population as normal. The tobacco companies have worked for years to target individuals living with mental illness, using psychology to market tobacco use as a way of coping and belonging while pocketing $37 billion from people living with mental illness who use tobacco products. Nicotine addiction is treatable in individuals living with mental and behavioral health challenges. While conventional methods of tobacco cessation do not work with this population, there are ways to tailor tobacco treatment so that it can be effective for individuals living with mental illness.

Luka Kinard became addicted to Juul when he was 14. Now 17 years old, he shares his story in hopes of helping others who are also fighting Juul addiction. Hear the conversation (about 45 minutes) between Luka and his mom, Kelly, where they discuss Luka’s journey with Juul addiction and how he has battled his addiction (and continues to daily) in exchange for getting his life back.

This presentation by Dr. Zim Okoli discusses Tobacco Treatment and Mental Illness. It outlines a brief background on tobacco product use, discusses the tobacco use epidemic among people with mental illness (MI), and reports behavioral treatment considerations and pharmacotherapy for tobacco treatment among people with MI.

Dr. Zim Okoli created this presentation to address tobacco treatment policies in behavioral health settings. The presentation explores a logic model for implementing and evaluating processes needed to provide a healthy environment to achieve wellness and recovery goals by de-normalizing tobacco use and promoting tobacco cessation.